NCT03870087 - PRECISION GRX Post-Market Study - Japan | Biotech Hunter

Enrollment

242

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

October 9, 2020

Study Completion Date

October 9, 2020

Conditions

Coronary Artery Disease

Interventions

DEVICE

Robotic-assisted PCI

The CorPath GRX is intended for use in the remote delivery and manipulation of guidewires and rapid exchange balloon/stent catheters, and remote manipulation of guide catheters during percutaneous coronary intervention (PCI) procedures.

Trial Locations (8)

814-0001

Fukuoka Sanno Hospital, Fukuoka

830-0011

Kurume University Hospital, Kurume

096-8511

Nayoro City General Hospital, Nayoro

020-0023

Iwate University Hospital, Morioka

259-1193

Tokai University Hospital, Isehara

153-0044

Toho University Ohashi Medical Center, Tokyo

321-0293

Dokkyo Medical University Hospital, Mibu

160-8582

Keio University Hospital, Shinjuku-ku